Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4105-4108

  Duncan, Virginia E ^a   Ajmani, Preeti S ^a   Hughes, Jeffrey A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antisense ODNs; Drug delivery; Telomerase; Telomeres; TRAP assay

Indexed keywords

OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TELOMERASE; TUMOR MARKER;

ARTICLE; CANCER; CANCER CELL CULTURE; CELL LYSATE; CELL TRANSPORT; CHROMOSOME REPLICATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TELOMERE;

BIOLOGICAL TRANSPORT; ELECTROPORATION; ENZYME INHIBITORS; HUMANS; NEUROBLASTOMA; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; TELOMERASE; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0032439330     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
2. Chadeneau C, Siegel P, Harley CD, Muller WJ and Bachhetti S: Telomerase activity in normal and malignant murine tissues. Oncogens 11: 893-898, 1995.
3. Counter CM, Gupta J, Harley CB, Leber B and Bachhetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 91: 2315, 1995.
4. Ghosh MK, Ghosh K, Dahl O and Cohen JS: Evaluation of some properties of a phophorodithioate oligodeoxyribonucleotide for antisense application. Nucl Acids Res 21: 5761-5766, 1993.
5. Schreier H: The new frontier: gene and oligonucleotide therapy. Pharm Acta Helv 68: 145-159, 1994.
6. Wagner RW: Gene inhibition using antisense oligodeoxynucleotides. Nature 372: 333-335, 1994.
7. Norton JC, Piatyszek MA, Wright WE, Shay JW and Corey DR: Inhibition of human telomerase activity by peptide nucleic acids. Nature 14: 615-619, 1996.
8. Giovannangeli C, Perrouault L, Escude C, Nguyen T and Helene C: Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator, conjugates targeted to HIV proviral DNA. Biochemistry 35: 10539-10548, 1996.
9. Grigoriev M, Praseuth D, Robin P, Hemar A, Saison-Behmoaras T, Dauty-Varsat A, Thuong NT, Helene C and Harel-Bellan A: A triple helix-forming oligonulceotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha- regulatory sequence. J Biol Chem 267: 3389-95, 1992.
10. Bock LC, Griffin LC, Latham JA, Vermaasand EH and Toole JJ: Selection of single stranded DNA molecules that bind and inhibit human thrombin. Nature 355: 564-566, 1992.
11. Flanagan WM and Wagner RW: Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem 172: 213-225, 1997.
12. Abdel Mageed A and Agrawal KC: Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4: 199-207, 1997.
13. Bergan R, Connell Y, Fahmy B and Neckers L: Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res 21: 3567-3573, 1993.
14. Lewis JG, Lin KY, Kothavale A, Flanagan WM, Matteucci MD, DePrince RB, Mook RA Jr, Hendren RW and Wagner RW: A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA. 93: 3176-3181, 1996.
15. Lappalainen K, Urtti A, Soderling E, Jaaskelainen I, Syrjanen K and Syrjanen S. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CASki cells. Biochim Biophys Acta 1196: 201-208, 1994.
16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho-PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
17. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE and Shay JW: Detection of telomerase activity by a telomeric repeat amplification protocol (TRAP). Methods in Cell Science 17: 1-15, 1995.